Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Isis Pharmaceuticals
Isis Pharmaceuticals
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
Isis Earns $3 Million Payment as Collaboration With GSK Expands
Yahoo
Mon, 05/16/11 - 11:45 am
GSK
milestone payments
Isis Pharmaceuticals
Isis Pharma Loss Widens
Yahoo/Zacks.com
Mon, 05/9/11 - 04:58 pm
Isis Pharmaceuticals
earnings
Isis Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Fri, 05/6/11 - 09:12 am
Isis Pharmaceuticals
earnings
Genzyme, Isis Say Mipomersen Cut LDL-C in Two Studies
Bloomberg
Tue, 04/5/11 - 10:49 am
Isis Pharmaceuticals
Genzyme
mipomersen
LDL-C
4-Star Stocks Poised to Pop: Isis Pharmaceuticals
Motley Fool
Tue, 03/8/11 - 11:35 am
Isis Pharmaceuticals
Narrower Q4 Loss at Isis
Yahoo/Zacks.com
Thu, 03/3/11 - 07:23 am
earnings
Isis Pharmaceuticals
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Amylin
Alnylam
Celldex
Exelixis
Human Genome Sciences
Isis Pharmaceuticals
Lexicon Pharmaceuticals
Neurocrine
Nektar
ONYX Pharmaceuticals
Ziopharm
Seattle Genetics
FDA Rejection Would Take Isis Stock Down
Seeking Alpha
Thu, 02/3/11 - 11:47 am
FDA
mipomersen
Orexigen
Contrave
Isis Pharmaceuticals
A Clear Drug-Development Path -- Times 2
Motley Fool
Wed, 01/12/11 - 12:06 pm
drug development
Isis Pharmaceuticals
Genzyme
mipomersen
Isis Pharma adds cancer, obesity drugs to pipeline
Yahoo/AP
Thu, 01/6/11 - 01:15 pm
cancer
Isis Pharmaceuticals
obesity
Loss Widens at Isis Pharma
Yahoo/Zacks.com
Mon, 11/15/10 - 08:48 pm
earnings
Isis Pharmaceuticals
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Alnylam
Novartis
Biogen Idec
Roche
Isis Pharmaceuticals
Cubist Pharmaceuticals
Takeda
earnings
Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air
Seeking Alpha
Fri, 09/3/10 - 08:10 am
Genzyme
Isis Pharmaceuticals
mipomersen
3 Stocks to Play Biotech
Motley Fool
Mon, 08/9/10 - 02:17 pm
Dendreon
ONYX Pharmaceuticals
Geron
Isis Pharmaceuticals
InterMune
Isis takes larger 2Q loss on as spending rises
Yahoo/AP
Mon, 08/9/10 - 09:52 am
Isis Pharmaceuticals
earnings
Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
Yahoo
Wed, 08/4/10 - 07:57 am
Genzyme
Isis Pharmaceuticals
mipomersen
cholesterol
clinical trials
Safety is key for upcoming Isis cholesterol data
Reuters
Mon, 08/2/10 - 10:17 am
Isis Pharmaceuticals
clinical trials
cholesterol
There Is Life After Death, At Least In Biotech
Investopedia
Tue, 06/22/10 - 10:35 am
biotech
Celgene
Genzyme
Gilead Sciences
Isis Pharmaceuticals
Vivus
Neurocrine
Nektar
Sanofi May Pay Regulus Up to $750 Million in Deal
Bloomberg
Tue, 06/22/10 - 09:00 am
Sanofi
Regulus
drug development
Isis Pharmaceuticals
Alnylam
fibrosis
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »